There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

The Reserve Bank of India will mandate unique transaction identifiers (UTIs) for all over-the-counter derivative trades starting January 1,...

Standard Chartered Bank has carried out the maiden over-the-counter derivative deal for hedging gold price risk from the Gujarat Internatio...

Under the format, information pertaining to deal type whether brokered or direct ISIN, listed or unlisted security, issuer name, coupon rat...

The Reserve Bank has mandated that all OTC foreign exchange, interest rate and credit derivative transactions, both inter-bank and client, ...

The group is looking to rope in a financial partner to play up its inorganic strategy of acquiring small OTC brands and businesses, said so...

Novartis's board approved sale of its OTC division to GSK Consumer Pvt Ltd, a consumer healthcare JV between Novartis AG & GSK, for a consi...

According to top executives from both the companies, Ranbaxy's OTC portfolio is going to be one of the key segments for Sun Pharma with sig...

JBCPL said it has completed Rs 939 crore deal to sell its over-the-counter business in Russia & CIS nations to Johnson & Johnson arm Cilag ...

The deal is expected this week and will be under 50 crore, one of the officials said, requesting anonymity.

Surya Pharmaceuticals has entered the over-the-counter (OTC) segment in healthcare with the acquisition of US brands.

The sale of contraceptive brand I-pill by Cipla to Piramal Healthcare may appear to be a win-win deal for both the companies.

Piramal Healthcare bought Cipla’s oral contraceptive brand, i-pill, for Rs 95 crore, to achieve its target of trebling its over-the-counter...

Maneesh has become the fourth Indian pharma firm after Sun Pharmaceuticals, Wockhardt and Glenmark, to acquire control of an American drug ...

Pharma majors are betting big on revenues from ubiquitous local grocers and paan stores in India.

Paras Pharmaceuticals iwants to acquire brands, or OTC companies, that would fit in with its growth plans.

After banks, non-banking finance companies and co-operative banks, the Reserve Bank of India’s regulatory reach on all derivative trades co...